1. Alekseeva, L.I. Obezbolivayuschie preparaty v terapevticheskoy praktike/ L.I. Alekseeva, E.G. Filatova, E.V. Moroz, V.P. Tyurin, E.L. Nasonov. ‒ M.: IMA-PRESS Karateev A.E., 2013. ‒ 134 s.
2. Giorgi, M. Robenacoxib: a review of its pharmacological properties and therapeutic usein dogs and cats / M. Giorgi // Journal of Veterinary Pharmacology and Therapeutics. ‒ 2017. ‒ No. 40(1). ‒ pp. 1-17.
3. Giraudel, J.M. Development of in vitro assays for the evaluation of cyclooxygenase selectivity and pharmacokinetics of robenacoxib, a new nonsteroidal anti-inflammatory drug in dogs / J.M. Giraudel, P.L. Toutain, P. Lees // American Journal of Veterinary Research. ‒2005. ‒ No. 66(6). ‒ pp. 938-945.
4. King, J.N. Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2 / J.N. KingJ., Dawson, R.E. Esser, R. Fujimoto, E.F. Kimble, S. Mani, P.L. Toutain // Journal of Veterinary Pharmacology and Therapeutics. ‒ 2009. ‒ No. 32(1). ‒ pp. 1-17.
5. Lascelles, B.D.X. Gastrointestinal tract perforation in dogs treated with a selective cyclooxygenase-2 inhibitor: 29 cases (2002–2003) //B.D.X. Lascelles, A.T. Blikslager, S.M. Fox, D. Reece //Journal of the American Veterinary Medical Association. ‒ 2005. ‒ No. 227(7). ‒ pp. 1112-1117.
6. Lees, P. Pharmacodynamics and pharmacokinetics of robenacoxib in the dog / P. Lees, J. Giraudel, M.F. Landoni, P.L. Toutain // Veterinary Record. ‒ 2015. ‒ No. 176(6). ‒ pp. 148.
7. Mansa, S. Long term treatment with carprofen of 805 dogs with osteoarthritis / S. Mansa, E. Palmer, C. Grondahl, et al. // Vet Record. ‒ 2007. ‒ No. 160. ‒ pp. 427-430.
8. Technical Bulletin for Onsior® (robenacoxib). ElancoAnimalHealth. (Aktual'naya versiya instrukcii k preparatu) https://assets.elanco.com/0cec44ed-3eaa-0009-2029-666567e7e4de/f46b2ec2-c33d-4e93-8370-0dd6cb8399e3/2021-10-15_Onsior%20tab_Instr%20%281%29.pdf
9. https://www.ema.europa.eu/en/vich-gl43-target-animal-safety-pharmaceuticals-scientific-guideline